CorMedix FCO/Dettes

Que fait CorMedix ? CorMedix Inc is a pharmaceutical company based in Berkeley Heights, New Jersey, operating within the Health Care sector. The company has 191 employees and went public via an IPO on March 25, 2010. Its website is https://cormedix.com/. CorMedix focuses on developing therapeutic products for the prevention and treatment of diseases and conditions, particularly targeting life-threatening scenarios. The company's primary product, DefenCath, is an antibacterial and antifungal solution designed to prevent bloodstream infections associated with central venous catheters in patients requiring chronic hemodialysis. DefenCath combines taurolidine at 13.5 mg/mL with heparin at 1000 USP Units/mL, intended for use in clinical settings such as hemodialysis, total parenteral nutrition, and oncology to reduce catheter-related infections and thrombosis. The company has also engaged in pre-clinical research collaborations involving taurolidine. CorMedix operates with a focus on addressing critical healthcare needs through innovative therapeutic solutions, though specific details about other products or ongoing research beyond the mentioned collaboration are not provided in the available information. CorMedix est l'une des entreprises les plus populaires sur Eulerpool.